News

CorMedix is a bio-pharmaceutical company that produces DefenCath, an antimicrobial catheter lock solution containing ...
This is an important study that combines replications of findings and novel detailed MRI investigations to assess the impact of environmental enrichment and maternal behavior on mice brain structure ...
Gland Pharma rose 1.62% to Rs 1,772 after the company announced that it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (USFDA), indicating the closure ...
Futures contracts, particularly due to their prevalence in other industries, have working case studies that highlight the ...
CorMedix raised its second-quarter sales forecast on Monday after disclosing that its large dialysis organization (LDO) ...
Anterior chamber irrigation with a 100 U/ml heparin solution immediately after trephination of the recipient cornea has also been suggested to prevent fibrin formation, subsequent synechiae and ...
CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced the pricing of ...
After nearly three decades at University of Toledo Medical Center, from inpatient pharmacist to hospital executive, Russell Smith, PharmD, is now applying his extensive clinical background to lead ...
We came across a bullish thesis on CorMedix Inc. (CRMD) on Archetype Capital’s Substack. In this article, we will summarize ...